ULS compared with AIDX: revenue, margins and what each company keeps, and the suppliers and customers both name

ULSUL Solutions Inc.

Mkt capRevenueRevenue

AIDX20/20 Biolabs, Inc.

Mkt capRevenueRevenue

Compare

ULSUL Solutions Inc.

AIDX20/20 Biolabs, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ULS2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±9.0%▲+7.00%×0.78

Q2 FY26—▼−13.96%—

AIDX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−6.21%—

= impliedULS realized, solidAIDX realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

ULSUL Solutions Inc.

78.72▲+3.37%· post 78.72

Mkt cap$15.9BRevenue$823MQ3 FY26Revenue$3.1BFY25

AIDX20/20 Biolabs, Inc.

0.24▲+28.73%· post 0.20

ClosedNov 6 '26

Mkt cap$2.1MRevenue$730,571Q2 FY26Revenue—

Compare

ClosedNov 6 '26

ULSUL Solutions Inc.

AIDX20/20 Biolabs, Inc.

78.72▲+3.37%post 78.72

Price

0.24▲+28.73%post 0.20

$15.9B

Mkt cap

$2.1M

Q3 FY26$823M

Revenue

$730,571Q2 FY26

FY25$3.1B

Revenue

—

ULS78.72▲+3.37%vsAIDX0.24▲+28.73%ClosedNov 6 '26